LPL Financial
XENE icon

LPL Financial’s Xenon Pharmaceuticals XENE Stock Holding History

LPL Financial’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Sell
4,838
-126
-3% -$7K ﹤0.01% 5483
2026
Q1 		$289K Buy
+4,964
New +$229K ﹤0.01% 5213
2021
Q1 		– Sell
-13,251
Closed -$204K – 4152
2020
Q4 		$204K Buy
+13,251
New +$155K ﹤0.01% 3508

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LPL Financial's XENE Position: Q2 2026 in Review

LPL Financial reduced its Xenon Pharmaceuticals (XENE) stake by 2.5% in Q2 2026, selling an estimated $7K and leaving 4,838 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #5483.

LPL Financial first reported a position in XENE in Q4 2020 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • LPL Financial held 4,838 shares of Xenon Pharmaceuticals worth $292K as of Q2 2026.
  • LPL Financial sold 126 Xenon Pharmaceuticals shares in Q2 2026, an estimated $7K.
  • Xenon Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5483 holding.
  • LPL Financial first reported a position in Xenon Pharmaceuticals in Q4 2020 and has held it in 3 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.